| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cifra de Afaceri - Ron | 1.900 | 8.425 | 1.128 | 0 | 0 | 32.093 | 210.015 | 976.701 | 1.306.803 | 1.793.441 |
| Venituri Totale - Ron | 2.900 | 34.925 | 1.128 | 1.000 | 1.064 | 341.495 | 340.845 | 1.029.186 | 1.330.022 | 1.944.229 |
| Cheltuieli Totale - Ron | 427 | 33.067 | 564 | 0 | 0 | 311.563 | 326.997 | 729.509 | 996.753 | 1.436.788 |
| Profit/Pierdere Brut - Ron | 2.473 | 1.858 | 564 | 1.000 | 1.064 | 29.932 | 13.848 | 299.677 | 333.269 | 507.441 |
| Profit/Pierdere Net - Ron | 2.386 | 1.160 | 553 | 990 | 1.054 | 29.611 | 9.579 | 289.591 | 320.455 | 449.114 |
| Salariati | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 4 | 3 | 8 |
Verifica rapoartele financiare pentru firma - Dalumaxin S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Active Imobilizate | 12.263 | 17.689 | 50.450 | 438.170 | 1.352.864 | 1.892.101 | 2.049.463 | 2.068.098 | 1.986.021 | 2.046.242 |
| Active Circulante | 2.471 | 8.971 | 1.029.990 | 807.746 | 665.828 | 576.288 | 249.581 | 266.421 | 256.031 | 354.897 |
| Stocuri | 55 | 280 | 147 | 2.504 | 2.505 | 77.576 | 35.021 | 72.801 | 156.666 | 106.575 |
| Creante | 749 | 2.062 | 915.204 | 759.615 | 659.452 | 479.457 | 164.205 | 144.496 | 29.145 | 104.697 |
| Casa si conturi | 1.667 | 6.629 | 114.639 | 45.627 | 3.871 | 19.255 | 50.355 | 49.124 | 70.220 | 143.625 |
| Capitaluri Proprii | 5.827 | 7.187 | 7.739 | 8.729 | 9.783 | 39.394 | -46.242 | 243.349 | 563.804 | 1.012.919 |
| Capital Social | 200 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 |
| Datorii | 13.098 | 37.164 | 206.376 | 409.063 | 1.226.051 | 1.521.195 | 1.458.108 | 1.255.541 | 926.257 | 688.622 |
| Venituri in Avans | 0 | 0 | 907.800 | 907.800 | 907.800 | 907.800 | 887.178 | 835.629 | 751.991 | 699.598 |
| Curs valutar - RON | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| CAEN Principal | "5520 - 5520" | |||||||||
| CAEN An Financiar |
5520
|
|||||||||
Comentarii - Dalumaxin S.r.l.